Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis”

678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 678 results

Large-scale testing (Phase 3)Study completedNCT02908152
What this trial is testing

Curcumin Supplement in Nonalcoholic Fatty Liver Patients

Who this might be right for
Type 2 DiabetesNonalcoholic Fatty Liver
National Nutrition and Food Technology Institute 50
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Large-scale testing (Phase 3)Study completedNCT05768334
What this trial is testing

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLD
Helwan University 116
Large-scale testing (Phase 3)Study completedNCT01245608
What this trial is testing

Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

Who this might be right for
Cardiovascular Diseases
Tehran University of Medical Sciences 2,400
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Large-scale testing (Phase 3)Study completedNCT01529268
What this trial is testing

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 169
Early research (Phase 1)Ended earlyNCT04766476
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Bristol-Myers Squibb 9
Not applicableStudy completedNCT01030484
What this trial is testing

Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2

Who this might be right for
Liver Disease
Johns Hopkins Bloomberg School of Public Health 2,501
Testing effectiveness (Phase 2)Study completedNCT03576755
What this trial is testing

Spironolactone Therapy In Young Women With NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT04048135
What this trial is testing

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

Who this might be right for
NASH
89bio, Inc. 101
Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing

Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218
Not applicableLooking for participantsNCT04785937
What this trial is testing

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseSteatohepatitis, NonalcoholicLiver Fibroses
Azienda USL Reggio Emilia - IRCCS 50
Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Not applicableLooking for participantsNCT03190538
What this trial is testing

Nonalcoholic Steatohepatitis in Chinese Children

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Humanity and Health Research Centre 400
Testing effectiveness (Phase 2)Ended earlyNCT00529204
What this trial is testing

Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

Who this might be right for
Diabetes ComplicationsFatty Liver
University of California, Davis 1
Not applicableStudy completedNCT01446276
What this trial is testing

Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease

Who this might be right for
ObesityNonalcoholic Fatty Liver Disease
University of Aarhus 26
Early research (Phase 1)Study completedNCT05560607
What this trial is testing

Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicNAFLD+3 more
AstraZeneca 19
Not applicableNot Yet RecruitingNCT06623084
What this trial is testing

Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosis+1 more
Stefania Basili 132
Not applicableEnrolling By InvitationNCT00983463
What this trial is testing

Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver Disease
Vanderbilt University 45
Early research (Phase 1)Study completedNCT04146805
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects

Who this might be right for
Chronic Liver DiseaseNASH - Nonalcoholic Steatohepatitis
Blade Therapeutics 80
Load More Results